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ABSTRACT We aimed to examine associations between chronic airflow obstruction (CAO) and
unemployment across the world.
Cross-sectional data from 26 sites in the Burden of Obstructive Lung Disease (BOLD) study were used
to analyse effects of CAO on unemployment. Odds ratios for unemployment in subjects aged 40–65 years
were estimated using a multilevel mixed-effects generalised linear model with study site as random effect.
Site-by-site heterogeneity was assessed using individual participant data meta-analyses.
Out of 18710 participants, 11.3% had CAO. The ratio of unemployed subjects with CAO divided by
subjects without CAO showed large site discrepancies, although these were no longer significant after
adjusting for age, sex, smoking and education. The site-adjusted odds ratio (95% CI) for unemployment
was 1.79 (1.41–2.27) for CAO cases, decreasing to 1.43 (1.14–1.79) after adjusting for sociodemographic
factors, comorbidities and forced vital capacity. Of other covariates that were associated with
unemployment, age and education were important risk factors in high-income sites (4.02 (3.53–4.57) and
3.86 (2.80–5.30), respectively), while female sex was important in low- to middle-income sites (3.23
(2.66–3.91)).
In the global BOLD study, CAO was associated with increased levels of unemployment, even after
adjusting for sociodemographic factors, comorbidities and lung function.
Copyright ©ERS 2017. This ERJ Open article is open access and distributed under the terms of the Creative Commons
Attribution Licence 4.0.
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Introduction
Chronic airflow obstruction (CAO) is the primary characteristic of patients with chronic obstructive
pulmonary disease (COPD) and affects up to one in five adults, depending on where they live, according
to data from the Burden of Obstructive Lung Disease (BOLD) study [1]. COPD is expected to keep its
position as the third most important cause of death worldwide [2], and imposes a substantial burden on
quality of life [3] and healthcare utilisation [4]. So far, data on productivity-related burden of CAO or
COPD have been scant [4].
Only three population-based studies have provided employment rates in CAO [5–7]. ERDAL et al. [5]
showed that 55% of individuals with CAO from a general Norwegian population were in a paid job, versus
87% of controls without CAO. However, controls were younger and had higher levels of education and the
authors did not examine employment in multivariate analyses. JANSSON et al. [6] examined CAO-specific
disability in northern Sweden, but did not include a control group and did not report employment rates.
In the PLATINO (Latin American Project for Research in Pulmonary Obstruction) study undertaken in
five Latin-American countries, MONTES DE OCA et al. [7] showed that the workforce participation among
subjects with CAO was lower than in healthy subjects (41.8% versus 57.1%). However, in multivariable
analyses they found that higher age, dyspnoea, number of comorbid conditions, female sex and lower
education were associated with unemployment, whereas CAO was only of borderline significance.
The BOLD study is a large international study providing population-based estimates of the prevalence and
burden of CAO. One of the primary objectives of the BOLD study is to estimate disease burden in terms
of activity limitation and economic impact [8]. In the current analysis, we have compared estimates of
employment status in BOLD participants with and without CAO across the world.
Methods
The BOLD protocol has been published previously [8]. It was written in compliance with the Helsinki
declaration and is approved by local ethics committees at all sites. All participants provided written
consent.
Population
All participating sites were recruited from well-defined administrative areas with the goal of providing
representative samples of the local population of ⩾600 non-institutionalised persons aged ⩾40 years. The
current report includes participants from 26 sites (online supplementary material). Out of 22118
participants providing interview data, 18710 performed acceptable post-bronchodilator spirometry and
were included in the descriptive part of the current analysis. However, when analysing risk for
unemployment as outcome, all subjects aged ⩾65 years (defined here as retirees) and homemakers/
caregivers were excluded. After excluding these subjects, there were no CAO cases left in Tirana (Albania),
so this centre is not part of the analyses assessing the effect of CAO on unemployment. Online
supplementary table S1 lists sampling strategy and response rates for all sites.
Data collection
The BOLD study is a cross-sectional study based on a structured, face-to-face interview using standardised
questionnaires and pre-/post-bronchodilator spirometry. All study coworkers were trained and certified by
BOLD coordinating centres.
The interviews gathered information on smoking habits, education, job status, self-reported comorbidities
(hypertension, heart disease, diabetes, stroke and lung cancer) and respiratory symptoms (dyspnoea,
wheezing and chronic bronchitis).
Participants indicated whether they had worked for income at any time in the preceding year or if they
served as full-time homemakers/caregivers during that time frame. Since retirement was not formally
captured under occupation, we excluded anyone aged ⩾65 years from analyses involving employment
status. All other individuals not being categorised as working, homemakers/caregivers or retirees were
defined as unemployed. The main outcome for the current study was a dichotomous employment status
where retirees (⩾65 years) and homemakers/caregivers were excluded.
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Never-smokers were individuals who had smoked <20 packs of cigarettes during their lifetime, or less than
one cigarette daily for a year. Ex-smokers were those who reported an age at which they had stopped
smoking. Education was categorised according to the highest level of completed schooling and divided into
no schooling, primary school, middle school, high school, some college and completed college/university.
Dyspnoea was defined using the modified Medical Research Council (mMRC) questions (grades 0–4, see
online supplementary material for details) [9]. Subjects reporting being unable to walk for reasons other
than breathing problems were excluded from the dyspnoea variable. Wheezing was defined as attacks of
wheezing associated with dyspnoea in the past 12 months. Chronic bronchitis was defined as productive
cough on most days in 3 months per year for at least two consecutive years.
Post-bronchodilator spirometry was performed using a hand-held spirometer (EasyOne; ndd
Medizintechnik, Zürich, Switzerland) according to American Thoracic Society standards [10], before and
⩾15 min after inhalation of 200 μg salbutamol through a large-volume spacer. For quality control, all
individual manoeuvers were reviewed by a pulmonary function reading centre.
Predicted values of forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC
ratio were estimated from equations for caucasians from the third National Health and Nutrition
Examination Survey (NHANES-III) [11]. Spirometric CAO was defined as post-bronchodilator FEV1/FVC
below lower limit of normal (LLN).
Analysis
The sample size of the BOLD study was set to be able to provide robust CAO prevalence estimates at the
individual sites [8]. No power calculations were performed a priori for employment status.
For unadjusted comparisons of individuals with and without CAO, we used Pearson Chi-squared
(categorical variables) and t-tests (continuous variables). To illustrate differences in unemployment and
CAO in different parts of the world, we stratified descriptive analyses by high-income sites (Sydney
(Australia), Salzburg (Austria), Vancouver (Canada), London (UK), Tartu (Estonia), Hannover (Germany),
Reykjavik (Iceland), Maastricht (the Netherlands), Bergen (Norway), Krakow (Poland), Lisbon (Portugal),
Uppsala (Sweden), Lexington (KY, USA)) and low- to middle-income sites (Guangzhou (China), Mumbai
(India), Pune (India), Manila (Philippines), Nampicuan Talugtug (Philippines), Annaba (Algeria), Cape
Town (South Africa), Adana (Turkey), Kashmir (India), Sousse (Tunisia), Ile-Ife (Nigeria) and Fes
(Morocco)). Income categories were based on the gross national income per capita (GNIPC) of the
country, with the cut point between low-to-middle income and high income being GNIPC 10000 US$.
[12]. We also calculated a risk ratio for unemployment associated with CAO as the prevalence of
unemployment in CAO subjects divided by the prevalence of unemployment in non-CAO subjects, using
a log-binomial generalised linear model (in Stata (StataCorp, College Station, TX, USA) specified as glm
with fam(bin) and link(log)). A risk ratio >1 indicates higher risk of unemployment associated with CAO,
while a ratio <1 indicates lower risk of unemployment associated with CAO. To illustrate sex differences in
CAO status across sites, we tabulated study sites and CAO status, stratified by sex.
Multivariable analyses for the pooled dataset were conducted using a multilevel mixed-effects generalised
linear model (online supplementary material). An alternative approach would be a fixed-effect model. The
difference to the chosen mixed-effects approach would be that the latter treats the sites as a random
sample of all possible sites, whereas the former would tend to focus more exclusively on the sites that were
included in the study. The BOLD sites are in some sense a random sample of broader sites to which we
wish to make an inference.
The main predictor variable was spirometric CAO. We fitted five mixed models, all adjusting for site as a
cluster level variable. We first identified the total effect of CAO on unemployment in a model with no
additional covariates included (model 1). Model 2 added demographic variables (age, sex and education)
and smoking habits. Model 2 was extended into model 3 by adding comorbidities. Model 4 included FVC
in addition to model 3 covariates. As our multivariable analyses include height, age and sex, which are the
main components when using % predicted values, we thus chose to analyse lung function in terms of
absolute values. In addition, a recent publication from the European Community Respiratory Health
Survey III study has indicated that FVC in absolute values (lung size) is able to explain most of the
difference in symptom burden between males and females [13]. FVC is a robust indicator of lung disease,
especially when obstruction is already taken into account. In addition, we included model 5 with
respiratory symptoms in addition to the model 4 covariates (online supplementary material). Details of
comorbidities and symptoms are presented in the online supplementary material. Covariates added in each
model were added not as independent risk factors for unemployment, but as potential confounding or
mediating factors influencing the effect of CAO on unemployment. In addition, models 2–5 were
performed separately for high-income sites and for low- to middle-income sites.
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In individual participant data meta-analyses, we estimated site-specific and overall odds ratios for CAO on
unemployment in forest plots, with increasing adjustment corresponding to models 1–5 (except for the
site adjustment). The Stata command used was ipdmetan which performs a two-stage individual
participant data meta-analysis using the inverse-variance method. Unlike traditional meta-analysis, the
individual participant data meta-analysis in ipdmetan fits a specified model to the data of one site at a
time, making use of all individual participants within the sites. The two-stage approach derives aggregate
data in each site separately and then combines these in a traditional meta-analysis model. The I2 statistic
was reported to display the percentage of total variation across sites which was due to true site-by-site
heterogeneity rather than what would be expected by chance alone (see the online supplementary material
for more details) [14].
All analyses were performed using Stata SE version 14 for Macintosh OSX.
Results
Out of 18710 participants, 2123 (11.3%) had CAO. Compared to subjects without CAO, those with CAO
were older, had lower education levels, more smoking exposure, more comorbidities, more respiratory
symptoms and substantially lower FEV1 (table 1). Overall, CAO was more common in males than in
females. However, site-specific prevalence estimates stratified by sex showed that for some centres the sex
ratio was reversed (online supplementary table S2). Excluding those aged ⩾65 years, 36.7% of participants
with CAO reported paid work during the preceding year, whereas 53.2% of participants without CAO had
undertaken paid work during the preceding year.
Figure 1 shows that more males than females reported current paid employment in both high- and low- to
middle-income countries, but the difference was larger in low- to middle-income countries. This appeared
to be explained by a substantial proportion of female unpaid homemakers/caregivers in low- to
middle-income countries. More details on sex differences in employment status are given in online
supplementary table S3.
Table 2 shows unemployment by CAO status in each study site, excluding homemakers, caregivers and
retirees (subjects aged ⩾65 years). Despite a wide variation in unemployment rates by site, there was a
fairly consistent pattern of higher unemployment among individuals with CAO in high-income sites. This
pattern was less clear in the low- to middle-income sites.
In multivariable analyses, we assessed the odds ratio of being unemployed by CAO status and an
increasing number of covariates (table 3). The first model showed that when we adjusted for site, the odds
ratio (95% CI) of being unemployed was 1.79 (1.41–2.27) for participants with CAO. Adding the
traditional confounders sex, age, smoking habits and education in model 2 decreased the odds ratio for
unemployment in participants with CAO (OR reduction from 1.79 to 1.44), but the effect remained
statistically significant. Further addition of comorbidities (model 3) and FVC (model 4) had little effect on
the association between unemployment and CAO, even when these variables themselves were significantly
associated with unemployment: the presence of comorbidities and declining FVC were all associated with
increased odds of being unemployed. Table 3 shows that excess unemployment among those with CAO is
partially explained by sex, age, smoking and education, but not explained additionally by comorbidities
and FVC. When respiratory symptoms were added (online supplementary table S4), these were also
significantly associated with unemployment and appeared to explain some of the effects of CAO. In this
model, the odds ratio for CAO independent of reported symptoms fell to 1.26 (95% CI 1.00–1.57).
Substituting self-reported COPD for LLN-defined CAO in our analyses increased the odds ratio of not
being in paid work from 1.43 (95% CI 1.14–1.79) to 3.31 (95% CI 2.17–5.05) (additional analysis, data not
shown). However, while the prevalence of spirometry-defined CAO was 11.3% in BOLD, the prevalence of
self-reported COPD was only 1.2%, and while 36.7% of the spirometry-defined participants with CAO
were in paid employment, the corresponding figure for the self-reported COPD cases was only 25%
(results not shown).
To examine how the observed associations varied by country income, we performed multivariable analyses
separately for high-income and low- to middle-income sites (table 4). CAO was a significant risk factor for
unemployment in all models in high-income sites, but not in low- to middle-income sites. While age and
lower education level were important risk factors for unemployment in high-income sites, female sex was
the most pronounced risk factor for unemployment in low- to middle-income sites. To further depict the
sex variation in job status, we created online supplementary table S3, which shows the prevalence of job
status categories among males and females in each site. This table illustrates that almost no sites had more
females than males in paid work (with Lexington, Lisbon and Ile-Ife as the only three exceptions). Further
on, focusing on the low- to middle-income sites, this table demonstrates that the difference in
“unemployed” job status between the sexes were very high in some sites, with the mean difference being
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46.1% more unemployed females than males. There were some sites that had more unemployed males
than females, but these were few (Annaba, Cape Town, Kashmir, Mumbai and Pune), and the mean
difference was low (5.5%). In model 5, dyspnoea was an additional important risk factor for
unemployment in high-income sites, together with age and education (online supplementary table S4).
To present the association between CAO and unemployment by site, and to examine site heterogeneity,
we performed individual participant data meta-analyses with forest plots of odds ratios and overall I2
statistics (figure 2 and online supplementary figures S1–S4). The overall odds ratio (95% CI) for
unemployment among CAO subjects after adjusting for sex, age, smoking, education, comorbidities and
FVC (i.e. the equivalent of model 4, but without site adjustment) was 1.41 (1.18–1.69) with site-by-site
heterogeneity (I2) of 12.9% (p=0.279). Meta-analyses with covariates corresponding to models 1, 2, 3
TABLE 1 Study participant characteristics in the Burden of Obstructive Lung Disease (BOLD)
study by chronic airflow obstruction (CAO)
Spirometric CAO No spirometric
CAO
Total
Subjects 2123 16587 18710
Female 46.4 (44.2–48.5) 51.9 (51.1–52.6) 51.3 (50.5–52.0)
Age years 60.7±11.9 55.2±11.0 55.8±11.3
Smoking
Never-smoker 33.9 (32.0–36.0) 57.2 (56.4–58.0) 54.6 (53.8–55.3)
Ex-smoker 31.0 (29.1–33.0) 23.9 (23.2–24.5) 24.7 (24.1–25.3)
Current smoker 35.1 (33.1–37.1) 18.9 (18.4–19.5) 20.8 (20.2–21.4)
Education
None 14.7 (13. 2–16.3) 12.1 (11.6–12.6) 12.4 (11.9–12.9)
Primary school 21.7 (20.0–23.5) 15.7 (15.2–16.3) 16.4 (15.9–16.9)
Middle school 17.0 (15.5–18.7) 16.0 (15.5–16.6) 16.1 (15.6–16.7)
High school 24.7 (22.9–26.6) 26.2 (25.5–26.8) 26.0 (25.4–26.6)
Some college 11.1 (9.8–12.5) 12.8 (12.3–13.4) 12.6 (12.2–13.1)
College/university 10.9 (9.6–12.3) 17.2 (16.6–17.8) 16.5 (15.9–17.0)
Job status
Paid work 36.7 (34.7–38.8) 53.2 (52.4–53.9) 51.3 (50.6–52.0)
Homemaker/caregiver 14.8 (13.3–16.4) 13.5 (13.0–14.0) 13.7 (13.2–14.1)
Unemployed 19.6 (18.0–21.4) 16.2 (15.6–16.8) 16.6 (16.1–17.1)
Above retirement age 28.9 (27.0–30.8) 17.1 (16.6–17.7) 18.5 (17.9–19.0)
Lung function
FVC % pred 89.2±21.8 90.3±16.1 90.2±16.9
FEV1 % pred 69.2±21.4 92.0±16.7 89.4±18.7
Self-reported doctor’s diagnosis
COPD 15.3 (13.8–16.9) 2.4 (2.2–2.6) 3.9 (3.6–4.2)
Hypertension 32.9 (30.9–34.9) 26.2 (25.6–26.9) 27.0 (26.3–27.6)
Heart disease 14.3 (12.9–15.9) 10.0 (9.5–10.4) 10.5 (10.0–10.9)
Diabetes 7.2 (6.1–8.3) 7.5 (7.1–7.9) 7.5 (7.1–7.9)
Stroke 3.1 (2.4–3.9) 1.9 (1.7–2.1) 2.0 (1.8–2.2)
Lung cancer 0.7 (0.4– 1.1) 0.2 (0.1– 0.3) 0.3 (0.2– 0.3)
Dyspnoea
mMRC 0 55.8 (53.5–58.0) 78.8 (78.1–79.4) 76.2 (75.6–76.9)
mMRC 1 17.1 (15.5–18.9) 12.1 (11.6–12.6) 12.7 (12.2–13.2)
mMRC 2 13.2 (11.7–14.8) 5.6 (5.2–5.9) 6.4 (6.1–6.8)
mMRC 3 8.5 (7.3–9.8) 2.7 (2.5–3.0) 3.3 (3.1–3.6)
mMRC 4 5.5 (4.5–6.6) 0.9 (0.7–1.0) 1.4 (1.2–1.6)
Attack of wheezing in past 12 months 22.3 (20.6–24.1) 6.3 (5.9–6.6) 8.1 (7.7–8.5)
Chronic bronchitis 15.4 (13.9–17.0) 5.1 (4.8–5.5) 6.3 (5.9–6.6)
Data are presented as n, % (95% CI) or mean±SD. n=18710 subjects from 26 study sites. All comparisons
between CAO and non-CAO were significant (p<0.01, Pearson Chi-squared test for categorical variables,
t-test for continuous variables) except for self-reported diabetes. Missing data: smoking habits n=11
(n=1 CAO, n=10 non-CAO); education n=25 (n=4 CAO, n=21 non-CAO); hypertension, diabetes, stroke, lung
cancer and heart disease n=1 (n=1 CAO); dyspnoea n=1834 (n=258 CAO, n=1576 non-CAO), mostly because
of other reasons for having trouble walking; wheezing n=11 (n=2 CAO, n=9 non-CAO); chronic bronchitis
n=0. FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; COPD: chronic obstructive pulmonary
disease; mMRC: modified Medical Research Council scale.
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and 5 are shown in online supplementary figures S1–S4, and show that there is no significant site
heterogeneity in the association between airflow obstruction and unemployment when adjusting for the
covariates in models 2, 3 and 5. However, in crude analysis (model 1), there is significant site
heterogeneity (I2 49.1%, p=0.003).
Discussion
The unweighted prevalence of spirometry-defined CAO was 11.3% in this sample of almost 19000
participants from the global BOLD study. The association between CAO and unemployment varied across
sites in crude analyses, but the site heterogeneity lost significance after adjustment for relevant covariates:
CAO was an overall important risk factor for unemployment after adjusting for sex, age, smoking,
education, comorbidities and even FVC. When looking at high-income and low- to middle-income sites
separately, this association was only statistically significant in high-income sites. Regarding other
covariates, age and education were important risk factors for unemployment in high-income sites, while
female sex was important for unemployment in low- to middle-income sites.
Comparable population-based studies have previously observed similar prevalence rates of COPD as the
CAO rates found in the present study. The PLATINO (Latin-American Pulmonary Obstruction
Investigation Project) study found the prevalence to be within the range of 7.8–19.7% [15], HANSEN et al.
[16] found the overall COPD prevalence in a Danish general population to be 12%, and the systematic
review by ADELOYE et al. [17] found the global prevalence of population-based spirometrically defined
COPD to be 11.7%.
Only one multicentre study has previously provided population-based estimates of unemployment in CAO,
identifying CAO using spirometry. In accordance with our findings, the PLATINO study, performed in
five Latin-American countries, estimated that 41.8% of participants with CAO and 57.1% of those without
CAO had a paid job the preceding year [7]. In the multivariable analysis of the PLATINO study they
found a borderline lower probability of paid work (OR 0.83, 95% CI 0.69–1.00) for CAO patients, and, as
in our study, they found significant effects of age, sex, education, dyspnoea and comorbidities. However,
the PLATINO study researchers adjusted for dyspnoea in their main model, and this has probably reduced
the effect of spirometry-defined CAO on the probability of having paid work. We observed the same
pattern in our study; while CAO was significantly associated with unemployment in our main model with
OR 1.43 (adjusting for sex, age, smoking, education, comorbidities and FVC), the odds ratio decreased to
1.26 (although still remaining significant, with 95% CI 1.00–1.57) after adding reported dyspnoea and
Female
a)
Paid work Unemployed Homemaker/caregiver Above retirement age 
(65 years)
Male
200 40
%
60 80 100
Female
b)
Male
200 40
%
60 80 100
FIGURE 1 Distribution of job status by sex for participants in a) high-, and b) low- to middle-income countries.
n=18 710.
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other respiratory symptoms. In line with this, we speculate that symptoms and severity of CAO would
probably explain the bulk of unemployment, and that it would be better to study these disease aspects
than merely spirometry measurements. However, even after adjusting for mMRC, wheezing with dyspnoea
and symptoms of chronic bronchitis in our study, the effect of spirometry-defined CAO on unemployment
was still significant (model 5; online supplementary material). This suggests that there are properties other
than the burden of current wheezing, dyspnoea and bronchitis that lead to unemployment, and adding
objectively measured CAO identifies the magnitude of these. For instance, the patient might experience
other symptoms (e.g. asthenia), be a frequent exacerbator or there might be some degree of reporting bias.
Other studies on workforce participation of CAO patients have been based on self-reported COPD
diagnosis and not spirometry [18–22]. Studies of self-reported COPD observe stronger associations
between the disease and participation in the workplace than the current study. This difference might be
due to a bias towards more severely affected patients in studies based on self-reports [23]. LAMPRECHT et al.
[24] showed that >80% of subjects with post-bronchodilator FEV1/FVC <LLN were undiagnosed, and that
less severe airflow obstruction was an important predictor lack of diagnosis.
The inclusion of undiagnosed CAO patients by state-of-the-art spirometric case detection in representative
population-based samples is the main strength of the current study. All epidemiological studies are subject
to selection bias to some degree, and the use of representative samples and mostly high cooperation rates
(over half >70%) reduce the likelihood of strong biases from selection. Furthermore, our main outcome is
categorical and objective, and less prone to bias [25, 26] than reports of diagnoses, although some of the
covariates may be more prone to recall bias. In addition, we have used post-bronchodilator measurements,
TABLE 2 Unemployment rates: prevalence of unemployment by site and spirometric chronic
airflow obstruction (CAO) status
Subjects# n Unemployment % Crude OR (95% CI)¶
CAO No CAO
Total 11675
High-income
Bergen, Norway 397 20.0 9.5 2.1 (1.0–4.2)
Hannover, Germany 361 25.0 20.8 1.2 (0.6–2.5)
Krakow, Poland 350 57.9 41.4 1.4 (1.0–1.9)
Lexington, USA 305 61.0 27.7 2.2 (1.6–3.0)
Lisbon, Portugal 320 53.9 39.8 1.4 (0.9–2.0)
London, UK 427 40.4 24.3 1.7 (1.1–2.4)
Maastricht, the Netherlands 396 31.3 20.4 1.5 (1.0–2.3)
Reykjavik, Iceland 557 14.0 3.3 4.2 (1.8–10.1)
Salzburg, Austria 860 35.2 25.4 1.4 (1.1–1.8)
Sydney, Australia 339 20.0 15.3 1.3 (0.6–3.0)
Tartu, Estonia 348 20.0 7.8 2.6 (0.9–7.5)
Uppsala, Sweden 371 23.8 6.0 4.0 (1.7–9.5)
Vancouver, Canada 594 21.8 11.5 1.9 (1.1–3.3)
Low- to middle-income
Adana, Turkey 487 41.1 45.4 0.9 (0.7–1.2)
Annaba, Algeria 408 50.0 24.6 2.0 (1.2–3.3)
Cape Town, South Africa 510 52.2 33.5 1.6 (1.2–2.0)
Fes, Morocco 335 41.7 53.7 0.8 (0.5–1.3)
Guangzhou, China 359 35.7 49.9 0.7 (0.4–1.5)
Ile-Ife, Nigeria 667 5.1 7.6 0.7 (0.2–2.7)
Kashmir, India 366 7.6 1.3 5.8 (1.5–22.9)
Manila, Philippines 594 10.3 19.5 0.5 (0.2–1.4)
Mumbai, India 250 17.7 10.3 1.7 (0.6–5.1)
Nampicuan Talugtug, Philippines 493 23.2 14.7 1.6 (0.9–2.7)
Pune, India 671 6.5 4.1 1.6 (0.4–6.4)
Sousse, Tunisia 390 53.3 46.1 1.2 (0.7–1.9)
Tirana, Albania 520 0.0 5.0
#: retirees (age limit defined as ⩾65 years) and homemakers/caregivers were excluded from the analysis.
¶: calculated based on prevalence of unemployment among subjects with CAO divided by prevalence of
unemployment among subjects without CAO. A ratio >1 indicates higher unemployment prevalence among
CAO subjects than among non-CAO subjects, while a ratio <1 indicates lower unemployment prevalence
among CAO subjects.
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in accordance with international guidelines, and we have a large sample size from a general global
population with standardised data collection across sites. In addition, we have built regression models
based on a priori hypotheses of associations, rather than including all variables that were significant in
bivariable analyses or by an automated stepwise approach.
Some limitations deserve to be mentioned. First of all, the BOLD study is a cross-sectional study, and as
such we cannot infer temporality and we have no direct evidence that the CAO was directly responsible
for the unemployment. It is not unthinkable that some of the association between CAO and
unemployment is a result of unemployed participants being more susceptible to the disease, even if we
have adjusted for education, age and smoking habits. Economic hardship in the form of unemployment
can worsen individual unhealthy behaviours including smoking [27]. Second, the employment question is
based on any paid work in the past year, and does not differentiate between full-time and part-time work.
In other words, subjects who have needed to reduce their work participation due to CAO from full-time to
part-time will still be defined as in paid work in our analysis. This may lead to an underestimation of
associations between CAO and employment. Being able to present absolute rates of disease-related
unemployment standardised at the site population level would have been an advantage, but as our data
did not include census information with age distribution details from each site this was not feasible.
Future research should preferably include such data for this purpose. Furthermore, lack of a direct
question on retirement means that we may have underestimated the problem of unemployment above 65
years of age. Our chosen cut-off of 65 years as retirement age may have affected results in both directions.
Third, our spirometry-derived variables were calculated from the NHANES III reference equation for
caucasians. This is relatively uncontroversial for measures of FEV1/FVC in the age group 40–65 years, as
normal values are not strongly associated with ethnicity. However, overall, the prevalence of
spirometry-defined CAO (FEV1/FVC <LLN) will be slightly lower with NHANES reference values than
with the recently recommended Global Lung Function Initiative reference values [28]. The difference
would not be large enough for us to expect substantial differences in the associations observed in the
present study. If anything, a higher CAO prevalence would lead to larger effects of CAO on
unemployment, including more individuals with less severe obstruction. The use of NHANES may be
more controversial for the measures of FVC than for the ratio measures. In this case, we have used FVC as
a continuous variable so that the “lower limit of normal” is not an issue, and, as we have allowed a
separate baseline in each centre and as most centres are ethnically homogeneous, this should not present a
problem [29, 30]. Since the main focus of the present study was on associations rather than prevalences,
TABLE 3 OR (95% CI) for unemployment for lower limit of normal-defined chronic airflow obstruction (CAO) and other risk
factors, with an increasing degree of adjustment (demographic characteristics, comorbidities and forced vital capacity (FVC))
Model 1 Model 2 Model 3 Model 4
Spirometric CAO 1.79 (1.41–2.27) 1.44 (1.15–1.81) 1.45 (1.15–1.82) 1.43 (1.14–1.79)
FVC 10 percentage points decrease in % pred 1.08 (1.04–1.12)
Female 2.07 (1.85–2.32) 2.10 (1.87–2.36) 2.10 (1.87–2.35)
Age 10-year increment 3.09 (2.85–3.35) 2.91 (2.68–3.15) 2.90 (2.67–3.15)
Smoking status
Current smoker 0.96 (0.83–1.10) 0.98 (0.85–1.13) 0.98 (0.85–1.13)
Ex-smoker 1.15 (1.01–1.32) 1.13 (0.99–1.30) 1.14 (0.99–1.30)
Education
Some college 1.51 (1.23–1.85) 1.49 (1.22–1.84) 1.49 (1.21–1.83)
High school 2.03 (1.71–2.42) 2.02 (1.69–2.41) 2.01 (1.68–2.39)
Middle school 2.24 (1.83–2.73) 2.20 (1.80–2.69) 2.18 (1.79–2.67)
Primary school 2.78 (2.27–3.41) 2.76 (2.25–3.39) 2.72 (2.22–3.35)
No education 2.73 (2.09–3.57) 2.69 (2.05–3.51) 2.66 (2.03–3.49)
Comorbidities
Hypertension 1.29 (1.13–1.46) 1.26 (1.10–1.43)
Heart disease 1.54 (1.27–1.86) 1.51 (1.25–1.83)
Diabetes 1.51 (1.23–1.85) 1.47 (1.19–1.80)
Stroke 1.82 (1.16–2.86) 1.80 (1.15–2.83)
Lung cancer 2.34 (0.81–6.76) 2.38 (0.82–6.93)
Adjustment variables: no fixed effects (model 1); age, sex, education and smoking (model 2); model 2 adjustment + comorbidities (model 3);
model 3 adjustment + FVC (model 4). All five models were fit using a multilevel mixed-effects generalised linear model with study site included
as random effect to account for within-site clustering. Reference values for categorical variables: no CAO, male, never-smoker, university
education, no hypertension, no heart disease, no diabetes, no stroke and no lung cancer. n=11675. Retirees (age limit defined as ⩾65 years)
and homemakers/caregivers were excluded from the analysis.
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we chose to implement the same reference values for the whole study population. This may allow for
possible factors that might have affected the lung function at a national level to become apparent, instead
of being lost with the use of different reference equations at each site. Fourth, regarding study limitations,
the registration of never-smokers may have been somewhat exaggerated if there were participants who
started smoking recently before study inclusion, but who had not yet reached 20 lifetime packs of cigarettes.
However, the risk of this would seem small given that the youngest participants included in the study are
aged 40 years. Lastly, there might be a bias toward more females responding as unemployed in low- to
middle-income sites due to cultural differences where females might not have formal employment, although
they attend work and have an informal income. This information bias might make the sex difference in the
risk of being unemployed somewhat higher than the actual risk in these sites, but unfortunately it is beyond
the potential of our dataset to disentangle this possible female misclassification. Online supplementary table
S3 shows that the differences between males and females applied to almost all sites.
The association between CAO and unemployment was significant in overall analyses, but in stratified
analyses we observed that the association was probably driven by high-income sites. There may be several
reasons for this. First, subjects in low- to middle-income countries may have more prevalent diseases than
CAO that render them vulnerable to unemployment. Second, there may be more heterogeneity in low- to
middle-income sites than in high-income sites. Our analyses showed consistent results across the
high-income sites that seemed to be more homogeneous than the low- to middle-income sites, where CAO
was a risk factor for unemployment in some sites and almost a protective factor against unemployment in
other sites. The suspicion was further strengthened by crude meta-analysis, showing significant site
heterogeneity in the univariate association between CAO and unemployment. However, when other
covariates were accounted for, the site heterogeneity lost significance. Third, other factors may be more
important than health factors for unemployment risk in low- to middle-income countries. We observed
that female sex was an important risk factor for unemployment in these sites, while age and education
TABLE 4 OR (95% CI) for unemployment for chronic airflow obstruction (CAO) and other risk factors, stratified by country
income category, with increasing degree of adjustment (demographic characteristics, comorbidities and forced vital capacity
(FVC))
Model 2 Model 3 Model 4
High income Low to middle
income
High income Low to middle
income
High income Low to middle
income
Spirometric CAO 1.71 (1.17–2.49) 1.16 (0.78–1.73) 1.63 (1.16–2.28) 1.18 (0.79–1.76) 1.68 (1.16–2.45) 1.15 (0.77–1.71)
FVC 10 percentage
points decrease in %
pred
1.09 (1.03–1.15) 1.08 (1.02–1.14)
Female 1.36 (1.16–1.59) 3.34 (2.76–4.04) 1.43 (1.23–1.68) 3.25 (2.68–3.94) 1.44 (1.23–1.68) 3.23 (2.66–3.91)
Age 10-year increment 4.28 (3.77–4.86) 2.31 (2.06–2.59) 4.04 (3.55–4.59) 2.21 (1.96–2.48) 4.02 (3.53–4.57) 2.20 (1.96–2.47)
Smoking status
Current smoker 1.34 (1.09–1.65) 0.88 (0.72–1.09) 1.36 (1.11–1.68) 0.89 (0.72–1.10) 1.36 (1.10–1.67) 0.89 (0.72–1.10)
Ex-smoker 1.31 (1.09–1.56) 1.15 (0.90–1.47) 1.28 (1.07–1.53) 1.13 (0.88–1.44) 1.29 (1.08–1.54) 1.12 (0.88–1.43)
Education
Some college 1.85 (1.45–2.38) 0.96 (0.60–1.52) 1.83 (1.43–2.36) 0.95 (0.60–1.52) 1.83 (1.42–2.35) 0.97 (0.61–1.54)
High school 2.30 (1.84–2.88) 1.26 (0.92–1.73) 2.27 (1.81–2.84) 1.28 (0.93–1.76) 2.24 (1.79–2.81) 1.30 (0.94–1.78)
Middle school 3.65 (2.73–4.87) 1.23 (0.89–1.70) 3.54 (2.64–4.74) 1.26 (0.91–1.74) 3.49 (2.60–4.67) 1.26 (0.91–1.75)
Primary school 4.14 (3.02–5.66) 1.52 (1.10–2.10) 3.90 (2.84–5.37) 1.56 (1.13–2.16) 3.86 (2.80–5.30) 1.56 (1.13–2.16)
No education 1.96 (0.61–6.32) 1.61 (1.13–2.30) 2.01 (0.62–6.43) 1.64 (1.15–2.34) 1.98 (0.61–6.43) 1.65 (1.15–2.35)
Comorbidities
Hypertension 1.25 (1.05–1.49) 1.25 (1.02–1.53) 1.22 (1.02–1.45) 1.22 (0.99–1.50)
Heart disease 1.56 (1.22–2.00) 1.20 (0.86–1.67) 1.53 (1.19–1.96) 1.18 (0.85–1.64)
Diabetes 1.53 (1.14–2.04) 1.39 (1.01–1.92) 1.46 (1.09–1.95) 1.38 (1.00–1.91)
Stroke 2.17 (1.14–4.13) 1.58 (0.83–3.02) 2.15 (1.13–4.10) 1.56 (0.82–2.99)
Lung cancer 2.87 (0.89–9.30) 1.01 (0.04–28.54) 2.86 (0.89–9.26) 1.03 (0.04–28.37)
Adjustment variables: no fixed effects (model 1); age, sex, education and smoking (model 2); model 2 adjustment + comorbidities (model 3);
model 3 adjustment + FVC (model 4). All five models were fit using a multilevel mixed-effects generalised linear model with study site included
as random effect to account for within-site clustering. Separate analyses were performed for high-income countries and low- to
middle-income countries. Reference values for categorical variables: no CAO, male, never-smoker, university education, no hypertension, no
heart disease, no diabetes, no stroke and no lung cancer. n=11675. Retirees (age limit defined as ⩾65 years) and homemakers/caregivers were
excluded from the analysis.
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were important for the high-income sites. Traditional male/female roles in low- to middle-income countries
may affect work-life participation to such a degree that they blur the association between health-related factors
and unemployment. Such large sex differences in work participation were illustrated in online supplementary
table S3 in the present study. And last, but not least, our results may be an indication of how disease
burden act differently in high-versus low- to middle-income sites, due to a strictly economic component.
In high-income sites those most severely affected are given the possibility to be economically sustained by
the corresponding social security systems, while in low- to middle-income sites such alternatives are few
or nonexistent. While in high-income sites, the welfare system bears the economic burden of disease, in
low- to middle-income sites the people affected both bear the personal and the economic burden of disease.
In conclusion, we have found that work-life participation of subjects with CAO is overall lower than
work-life participation of subjects without CAO, and that CAO is associated with unemployment after
adjusting for sex, age, smoking, education, comorbidities and even FVC. There was no significant
heterogeneity between sites, although stratified analyses showed that CAO may be of greater importance
for unemployment in high-income sites. Our study shows the risk of unemployment among people with
this prevalent respiratory disease, and illustrates how CAO considerably impacts productivity and social
security systems worldwide.
3210.0312
BOLD sites
Bergen, Norway
Hannover, Germany
London, UK
Maastricht, the Netherlands
Reykjavik, Iceland
Salzburg, Austria
Uppsala, Sweden
Lexington, USA
Sydney, Australia
Vancouver, Canada
Adana, Turkey
Krakow, Poland
Lisbon, Portugal
Tartu, Estonia
Annaba, Algeria
Cape Town, South Africa
Fes, Morocco
Ile-ife, Nigeria
Sousse, Tunisia
Guangzhou, China
Manila, Philippines
Mumbai, India
Pune, India
Nampicuan Talugtug, Philippines
Kashmir, India
Overall (I2 12.9%, p=0.279)
1.69 (0.65–4.39)
0.89 (0.34–2.33)
1.92 (1.04–3.53)
1.34 (0.69–2.63)
4.57 (1.44–14.47)
1.27 (0.69–2.34)
6.58 (1.55–27.94)
2.20 (0.88–5.51)
1.65 (0.57–4.79)
1.58 (0.75–3.31)
1.19 (0.64–2.18)
0.89 (0.39–2.00)
1.27 (0.48–3.33)
2.72 (0.53–14.07)
2.04 (0.67–6.25)
1.38 (0.81–2.35)
0.58 (0.22–1.57)
0.74 (0.16–3.45)
2.04 (0.54–7.75)
0.51 (0.16–1.64)
0.44 (0.15–1.27)
1.15 (0.20–6.75)
1.61 (0.30–8.52)
2.03 (0.88–4.70)
2.79 (0.73–10.59)
1.41 (1.18–1.69)
3.52
3.49
8.66
7.11
2.42
8.52
1.54
3.81
2.84
5.86
8.60
4.89
3.45
1.19
2.57
11.45
3.25
1.35
1.81
2.32
2.79
1.03
1.16
4.57
1.80
100.00
OR (95% CI) Weight %
FIGURE 2 Odds ratios (95% CI) for unemployment for lower limit of normal-defined chronic airflow obstruction, adjusted for demographic
characteristics, comorbidities and forced vital capacity (FVC). Adjustment variables: sex, age, smoking, education, hypertension, heart disease,
diabetes, stroke, lung cancer and FVC. n=11 675, meta-analysis with results across sites and overall. Retirees (age limit defined as 65 years) and
homemakers/caregivers excluded. BOLD: Burden of Obstructive Lung Disease study.
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